Ferring Pharmaceuticals acquires Gameto
Cell-based fertility treatments, biotech · USAacquired byFerring Pharmaceuticals
Ferring Pharmaceuticals, a Swiss pharmaceutical company for reproductive medicine, acquires the US biotech Gameto for up to $1.38bn, depending on milestones. Gameto develops cell-based therapies for women's health and fertility, including Fertilo for maturing eggs in the laboratory.
- Buyer
- Ferring Pharmaceuticals
- Target
- Gameto
- Type
- Strategic
- Sector
- Healthcare & Medtech
- Country
- USA
- First reported
- 28/10/2026
- Source
- BioPharma Dive
Deal-Radar no. 44-129 · publicly reported, without guarantee · SourcingClub was not involved in this transaction. Report an error · Method
Transactions by Ferring Pharmaceuticals
So far this is the only transaction by Ferring Pharmaceuticals published in the Deal-Radar. New deals are added every Monday.
Acquisitions abroad in Week 44/2026
All deals in October 2026Every Monday, all deals of the previous week, with source.
Information from public sources, without guarantee and without claim to completeness. No investment or legal advice. Published on 31 October 2026.